<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>Curierul Medical, 2016, Vol. 59, No 5</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/1129</link>
<description/>
<pubDate>Mon, 27 Apr 2026 16:21:39 GMT</pubDate>
<dc:date>2026-04-27T16:21:39Z</dc:date>
<item>
<title>Curierul medical. October 2016, Vol. 59, No 5</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/16198</link>
<description>Curierul medical. October 2016, Vol. 59, No 5
From its debut in 1958, the journal has striven to support the interests of&#13;
Moldovan medicine concerning the new concepts of its development. The&#13;
Editorial Board warmly welcomes both the readers of and the authors for the&#13;
journal, all those who are enthusiastic in searching the new and more effective&#13;
ways of solving numerous medical problems. We hope that those who want&#13;
to make their contribution into the science of medicine will find our journal&#13;
helpful and encouraging.&#13;
The journal is accredited by the National Council for Accreditation and&#13;
Attestation. The journal publishes official papers, scientific articles, editorials,&#13;
clinical studies and cases, lectures, methodological guides, reviews, brief reports, and correspondence. The journal welcomes articles in English, Romanian and&#13;
Russian. The journal editorial policy provides the prompt publication of papers&#13;
within 12 weeks after receiving them.; De la prima apariţie în 1958, revista susţine şi dezvoltă noile idei în&#13;
domeniul medicinii, în Republica Moldova. Colegiul de redacţie agrează cu&#13;
multă consideraţie atât cititorii cât şi autorii articolelor, pe toţi acei care cu mult&#13;
entuziasm caută noi şi mult mai efective metode de soluţionare a multiplelor&#13;
probleme ale medicinii. Sperăm, că toţi acei care doresc să-şi aducă aportul&#13;
la dezvoltarea ştiinţelor medicale, vor găsi revista noastră utilă şi atractivă.&#13;
Revista este acreditată de către Consiliul Naţional de Acreditare și Atestare.&#13;
Revista publică comunicări oficiale și, totodată, sunt editate diverse publicaţii,&#13;
inclusiv independente: articole știinţifice, editoriale, cercetări și prezentări de&#13;
cazuri clinice, prelegeri, îndrumări metodice, articole de sinteză, relatări scurte,&#13;
corespondenţe și recenzii. Revista publică articole în limba engleză, română și&#13;
rusă. Politica de editare a revistei prevede examinarea operativă și publicarea&#13;
articolelor timp de 12 săptămâni după înaintare.; С первого дня своего выпуска в 1958 году журнал стремится поддерживать и развивать новые идеи в области медицины в Молдове. Редакционная коллегия всегда рада как читателям, так и авторам статей,&#13;
всем тем, кто с энтузиазмом ищет новые, более эффективные способы&#13;
решения многочисленных задач медицины. Мы надеемся, что все те, кто&#13;
хотят внести свой вклад в медицинскую науку, найдут наш журнал полезным и вдохновляющим.&#13;
Журнал аккредитован Высшей Аттестационной Комиссией Республики Молдова. В журнале печатаются официальные материалы, научные статьи, наблюдения из клинической практики, обобщающие статьи,&#13;
краткие сообщения, методические указания, рецензии и корреспонденция. В журнале публикуются статьи на английском, румынском и русском языках. Издательская политика журнала предусматривает оперативное рассмотрение и публикацию статей в среднем в течение 12 недель после поступления.
Fondatori: Ministerul Sănătăţii al Republicii Moldova, Universitatea de Stat de Medicină şi Farmacie “Nicolae Testemiţanu”
</description>
<pubDate>Fri, 01 Jan 2016 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://repository.usmf.md:80/xmlui/handle/20.500.12710/16198</guid>
<dc:date>2016-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Illarion Postolachi to the 80th anniversary since the birth</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/13497</link>
<description>Illarion Postolachi to the 80th anniversary since the birth
Postolachi, Alexander
</description>
<pubDate>Fri, 01 Jan 2016 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://repository.usmf.md:80/xmlui/handle/20.500.12710/13497</guid>
<dc:date>2016-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Experience of Rottinger approach in hip replacement</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/2927</link>
<description>Experience of Rottinger approach in hip replacement
Fil, Adrian; Hut, Diana
Background: An important aspect in modern hip arthroplasty plays operative technique, namely the use of minimally invasive techniques and&#13;
low-traumatic manipulation. Since the beginning of the development of minimally invasive technologies in orthopedics and increasing demands on the&#13;
part of patients in the postoperative period there appeared a fast growing need to develop new minimally invasive approaches to achieve the objectives&#13;
as opposed to the existing traditional techniques.&#13;
Material and methods: The analysis of 47 patients operated on traditional access (Harding) – control group (20 patients with osteoarthritis, 27&#13;
with a fracture of the femoral neck) and 42 patients undergoing surgery for Rottinger approach – the main group (20 – coxarthrosis, 22 – fracture of the&#13;
femoral neck). A survey of patients and evaluation of Harris Hip Score were made.&#13;
Results: For evaluation of Harris Hip Score the following parameters were taken: the painful feelings when bearing load on the operated limb, the&#13;
ability to walk different distances (unlimited, 30 minutes, 15 minutes, only indoors, impossible), the opportunity to wear socks or shoes, use stairs with&#13;
no assistance, ability to perform daily activities and work, the need to use aids, limping, the ability to use public transport, sitting, operated joint mobility&#13;
(in degrees). Grading for the Harris Hip Score: &lt;70 – poor, 71-79 – fair, 80-89 – good, &gt;90 – excellent. The overall result for the Harris Hip Score using&#13;
Rottinger approach was 89.1 points, corresponding evaluation “good”, and Harding method – 72.8 (“fair”). 6 weeks after surgery score for Rottinger&#13;
approach was 95.3 points (“excellent”), Harding method – 82.4 points (“good”).&#13;
Conclusions: Cosmetic effect by Rottinger approach length of incision is 8-10cm, without myotomy and violation of the fascia lata integrity, better&#13;
visualization of the acetabulum, but worse is the proximal femur, the need for specialized tools. This operating technique provides a shorter period of&#13;
hospitalization, reduces the need for rehabilitation and support aids, reduces the risk of complications from prolonged immobilization, and reduces the&#13;
risk of dislocation by 4.15%.
</description>
<pubDate>Fri, 01 Jan 2016 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://repository.usmf.md:80/xmlui/handle/20.500.12710/2927</guid>
<dc:date>2016-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Surveillance of quinolone generations in Emergency Medicine Institute</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/2928</link>
<description>Surveillance of quinolone generations in Emergency Medicine Institute
Bernaz, Emilian P.
Background: The main goal of the study was to evaluate the institutional representative data on quinolones antibacterial generations in accordance with&#13;
WHO requirements, to determine the value of Defined Daily Doses per 1000 Occupied-Bed Days (DDD/1000) and cost in most important departments,&#13;
comparing it with the same published data of international scientific journals.&#13;
Material and methods: For this study we used the data of a six-year (2009-2014) period in the Emergency Medicine Institute and their subdivisions&#13;
with main consumption of antibiotics which shows the consumption dynamics of quinolone generations use in grams and value indexes.&#13;
Results: In the evaluated period, the medium yearly consumption of all quinolone generations recorded 63.03 DDD/1000 or a share of 11.14% from&#13;
medium annual total of 566.02 DDD/1000 antibiotics. The same data in other international hospitals recorded 71.24 or 11.84% from total of 601.36&#13;
DDD/1000. In the end of the evaluated period, in IC departaments, the consumption of the first and the second generations registered 112.13 DDD/1000&#13;
and respectively the third and the fourth 6.02 DDD/1000 or a decrease by 2.27 and 13.85 times. In SSOT departments in the end of the evaluation the&#13;
first and the second generations recorded 57.59 DDD/1000 or an increase by 40.25%. Medium annual cost per DDD/1000 for the first and the second&#13;
generations of quinolone antibacterials in ICD recorded 4731.78 lei, the third and the fourth generations 6526.15 lei and respectively in SSOTD 365.78&#13;
lei and 149.20 lei.&#13;
Conclusions: In the end of the evaluated period in ICD of EMI quinolones of the first and the second generations represent 94.90% and the third and&#13;
the fourth generations 5.10% from the total consumption. In SSOTD departments and in the entire EMI, the third and the fourth generations represent&#13;
less than 1% of all consumption. This evaluation, as a part of multidisciplinary approach, serves as an important point for further survey of protocols&#13;
and guides concerning the antibiotic consumption in one hospital.
</description>
<pubDate>Fri, 01 Jan 2016 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://repository.usmf.md:80/xmlui/handle/20.500.12710/2928</guid>
<dc:date>2016-01-01T00:00:00Z</dc:date>
</item>
</channel>
</rss>
